Therapeutic flag Cosmetic cross-reference

Silver Nitrate

CAS 7761-88-8

Silver Nitrate (CAS 7761-88-8) is a Phase 3 pharmaceutical compound with 1 bioactivity target and 38 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
1
SOURCE DrugCentral
Adverse signals
38
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Silver Nitrate
CAS Number
7761-88-8
UNII
95IT3W8JZE
InChIKey
SQGYOTSLMSWVJD-UHFFFAOYSA-N
ChEMBL ID
CHEMBL177367
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
natural producttherapeutic flag
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 3
Late-stage clinical development phase from the compound identifier source.
ChEMBL CHEMBL177367 | Small molecule
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →
SOURCE EMBL-EBI ChEMBL 1 bioactivity row

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

TargetActivity ValueAssaysOrganism
- MIC 5.571428571428571 ug.mL-1 21 -
SOURCE DrugCentral 19 associations

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PTDrug AE LLRMedDRA
Stoma site erythema 12 44.053 10074514
On and off phenomenon 14 43.837 10030312
Stoma site discharge 12 40.931 10075512
Fibroma 9 34.883 10016629
Exposure during pregnancy 42 30.351 10073513
Stoma site irritation 6 27.292 10059072
Bradykinesia 12 27.166 10006100
Alcohol abuse 11 26.876 10001584
Freezing phenomenon 8 23.588 10060904
Tension 9 22.326 10043268
Drug dependence 19 21.793 10013663
Muscle rigidity 13 19.598 10028330
Diarrhoea 111 19.287 10012735
Stoma site pain 6 19.132 10057843
Memory impairment 30 18.919 10027175
Stoma site haemorrhage 6 18.097 10074508
Stoma site inflammation 5 17.867 10065669
Atrial septal defect 11 17.243 10003664
Abnormal dreams 11 17.04 10000125

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE NLM RxNorm 3 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
SILVER NITRATE 9789 SU MTHSPL
Silver Nitrate 9789 SU MTHSPL
silver nitrate 9789 IN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Silver Nitrate used for in pharmaceutical contexts?

Silver Nitrate (CAS 7761-88-8) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Silver Nitrate?

Silver Nitrate has 38 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Stoma site erythema, On and off phenomenon, Stoma site discharge, Fibroma, Exposure during pregnancy. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Silver Nitrate also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Silver Nitrate with EU status "restricted".

What clinical phase is Silver Nitrate in?

Silver Nitrate is rendered with ChEMBL max phase 3.